- Chart
- Upturn Summary
- Highlights
- Valuation
- About
Moolec Science SA Warrant (MLECW)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/04/2025: MLECW (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -75% | Avg. Invested days 17 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta -0.32 | 52 Weeks Range 0.01 - 0.07 | Updated Date 06/28/2025 |
52 Weeks Range 0.01 - 0.07 | Updated Date 06/28/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -21.69% | Return on Equity (TTM) -174.68% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 897815 |
Shares Outstanding - | Shares Floating 897815 | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
Moolec Science SA Warrant
Company Overview
History and Background
Moolec Science SA is a biotechnology company focused on developing and producing proteins through cellular agriculture. The company leverages proprietary technology to create animal-free proteins for food and other applications. As a warrant, it represents a right to purchase shares of Moolec Science SA at a specified price within a certain timeframe. Specific founding year and milestones for the warrant itself are not directly applicable as it's a derivative instrument linked to the parent company's lifecycle.
Core Business Areas
- Protein Production via Cellular Agriculture: Moolec Science aims to produce proteins, such as those found in meat and dairy, without the need for animal agriculture. This involves using genetically modified microorganisms to ferment and produce specific proteins. The technology is intended to offer sustainable and ethical alternatives to traditional protein sources.
Leadership and Structure
Information on the specific leadership and structure of 'Moolec Science SA Warrant' as a separate entity is not available. The leadership and structure are that of the underlying company, Moolec Science SA. Further details would require direct consultation of Moolec Science SA's corporate filings.
Top Products and Market Share
Key Offerings
- Protein Ingredients: Moolec Science is developing protein ingredients derived from cellular agriculture. These are intended for use in the food industry to create products like plant-based meats and dairy alternatives. Specific market share data for Moolec Science's protein ingredients is not yet established as they are in the development and early commercialization phases. Competitors in the broader alternative protein market include companies focused on plant-based proteins (e.g., Impossible Foods, Beyond Meat) and other cellular agriculture companies (e.g., Upside Foods, GOOD Meat).
Market Dynamics
Industry Overview
The alternative protein market, including cellular agriculture, is a rapidly growing sector driven by consumer demand for sustainable, ethical, and healthier food options. Key trends include innovation in protein sources, scaling production, regulatory approvals, and consumer acceptance. The market is competitive with established food giants and numerous startups vying for market share.
Positioning
Moolec Science positions itself as an innovator in producing a broad spectrum of animal proteins through its cellular agriculture platform. Its competitive advantages may lie in its proprietary technology for producing various protein types and its focus on cost-effective scalability.
Total Addressable Market (TAM)
The global alternative protein market is projected to reach hundreds of billions of dollars in the coming years. Moolec Science is positioned to capture a portion of this TAM by offering novel protein ingredients for food applications.
Upturn SWOT Analysis
Strengths
- Proprietary cellular agriculture technology for protein production.
- Potential for high-volume, sustainable protein manufacturing.
- Focus on producing a diverse range of animal proteins.
Weaknesses
- Early-stage company with unproven large-scale commercial viability.
- Reliance on complex biotechnology and potential for high R&D costs.
- Need for significant capital investment for scaling production.
- Uncertainty regarding regulatory approvals for novel food ingredients.
Opportunities
- Growing consumer demand for sustainable and ethical food alternatives.
- Expansion into various food categories (meat, dairy, eggs, etc.).
- Partnerships with major food manufacturers.
- Advancements in biotechnology and fermentation processes.
Threats
- Intense competition from plant-based and other alternative protein companies.
- Potential for public skepticism or resistance to cell-based foods.
- Challenges in achieving cost parity with traditional animal proteins.
- Stringent and evolving regulatory landscapes.
- Technological hurdles in scaling production efficiently.
Competitors and Market Share
Key Competitors
- Impossible Foods
- Beyond Meat
- Upside Foods
- GOOD Meat
Competitive Landscape
Moolec Science SA competes in a rapidly evolving alternative protein market. Its key advantages lie in its cellular agriculture approach, aiming to produce a wider range of animal proteins than many plant-based competitors. However, it faces challenges in scaling production, cost, and gaining widespread consumer acceptance compared to more established plant-based alternatives. Competitors like Impossible Foods and Beyond Meat have a head start in market penetration and brand recognition.
Growth Trajectory and Initiatives
Historical Growth: Growth trajectory analysis would apply to Moolec Science SA, focusing on progress in R&D, regulatory milestones, and partnerships. As a warrant, its growth is directly tied to the potential appreciation of the underlying stock.
Future Projections: Future projections for Moolec Science SA would be based on the successful scaling of its cellular agriculture technology and market adoption of its protein products. Analyst estimates for Moolec Science SA would be the primary source.
Recent Initiatives: Recent initiatives for Moolec Science SA would likely involve advancements in their proprietary technology, securing funding, and building strategic partnerships in the food industry.
Summary
Moolec Science SA, through its warrants, represents an investment in a nascent cellular agriculture company. Its strength lies in its innovative technology for producing animal-free proteins, tapping into a growing market for sustainable food. However, it faces significant weaknesses in its early-stage development, high R&D costs, and intense competition. The company must overcome technological and scaling challenges while navigating a complex regulatory environment to capitalize on the substantial market opportunities in alternative proteins. Close monitoring of its technological advancements and market adoption is crucial.
Similar Stocks
Sources and Disclaimers
Data Sources:
- General industry knowledge of the alternative protein and cellular agriculture markets.
- Hypothetical data for market share comparison based on industry trends.
- General understanding of warrants as financial instruments.
Disclaimers:
This JSON output is a hypothetical representation and does not constitute financial advice. Data on market share and specific financial performance are illustrative and may not reflect the actual current state of Moolec Science SA or its competitors. Warrants are complex financial instruments with a high degree of risk. Investors should conduct their own thorough research and consult with a qualified financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Moolec Science SA Warrant
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2023-01-03 | CEO - | ||
Sector Healthcare | Industry Biotechnology | Full time employees - | Website https://moolecscience.com |
Full time employees - | Website https://moolecscience.com | ||
Moolec Science SA operates as a science-based food ingredient company. The company is based in Grand Cayman, Cayman Islands.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

